Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: a new challenge

Publication date: Available online 5 April 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Edgar Carnero Contentti, Jorge Correa
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research

Related Links:

Treatment of multiple sclerosis under the COVID-19 pandemic. Tidsskr Nor Laegeforen. 2020 May 26;140(8): Authors: Holmøy T, Torkildsen Ø, Bø L PMID: 32463200 [PubMed - in process]
Source: Tidsskrift for den Norske Laegeforening - Category: General Medicine Authors: Tags: Tidsskr Nor Laegeforen Source Type: research
Publication date: Available online 23 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Carlos Guevara, Eduardo Villa, Carlos Silva Rosas, Violeta Diaz, Rodrigo Naves
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 23 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Mahsa Ghajarzadeh, Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, Saeed Vaheb, Vahid Shaygannejad, Amir-Hadi Maghzi
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
DiscussionThe use of common tools for neurological examination could improve tele-neurology practice for both general neurologists and MS specialists, and quality of care for people with MS.
Source: Neurological Sciences - Category: Neurology Source Type: research
Publication date: Available online 16 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Ethel Ciampi, Reinaldo Uribe-San-Martin, Claudia Cárcamo
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 14 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Mohammad Ali Sahraian, Mohammad Reza Gheini, Nasim Rezaeimanesh, Mahsa Ghajarzadeh, Abdorreza Naser Moghadasi
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 12 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): David Baker, Sandra Amor, Angray S. Kang, Klaus Schmierer, Gavin Giovannoni
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
The COVID-19 pandemic has caused a number of disruptions in our health care system, one of which is the ability for seniors to access their infused or injected Part B medicines normally administered in a physician office or hospital outpatient setting. Many seniors are confined to their home during the pandemic because either their age or their health condition makes it far too dangerous to travel to a doctor ’s office, clinic or hospital. These seniors, suffering from complex diseases like multiple sclerosis, kidney disease, cancer, osteoporosis and immune disorders, among others, that require regular care, are amon...
Source: The Catalyst - Category: Pharmaceuticals Tags: Part B Source Type: news
We present a patient with MS treated with fingolimod who was diagnosed with COVID-19 and had a favorable outcome.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Tags: COVID-19, Multiple sclerosis Clinical/Scientific Notes Source Type: research
Investigators leading ongoing pivotal trials in Alzheimer's, multiple sclerosis, and stroke have had to make a quick pivot to change plans and protocols for key trials during the COVID-19 pandemic.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Brain | COVID-19 | Multiple Sclerosis | Neurology | Pandemics